S9 Ep34: FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia

OncLive® On Air - A podcast by OncLive® On Air

Podcast artwork

Dr Kuykendall discusses the FDA approval of momelotinib in myelofibrosis with anemia, key data from the MOMENTUM trial, and how momelotinib alters the myelofibrosis treatment paradigm.